Formidable Asset Management, LLC Cytom X Therapeutics, Inc. Transaction History
Formidable Asset Management, LLC
- $574 Million
- Q1 2025
A detailed history of Formidable Asset Management, LLC transactions in Cytom X Therapeutics, Inc. stock. As of the latest transaction made, Formidable Asset Management, LLC holds 353,840 shares of CTMX stock, worth $919,984. This represents 0.04% of its overall portfolio holdings.
Number of Shares
353,840
Previous 382,529
7.5%
Holding current value
$919,984
Previous $394,000
42.64%
% of portfolio
0.04%
Previous 0.07%
Shares
10 transactions
Others Institutions Holding CTMX
# of Institutions
67Shares Held
44.9MCall Options Held
8.9KPut Options Held
47.9K-
Tang Capital Management LLC San Diego, CA6.72MShares$17.5 Million0.28% of portfolio
-
Bvf Inc San Francisco, CA5.23MShares$13.6 Million0.15% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.12MShares$13.3 Million0.0% of portfolio
-
Prosight Management, LP Dallas, TX3.93MShares$10.2 Million0.9% of portfolio
-
Acadian Asset Management LLC Boston, MA3.23MShares$8.41 Million0.01% of portfolio
About CytomX Therapeutics, Inc.
- Ticker CTMX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 65,950,200
- Market Cap $171M
- Description
- CytomX Therapeutics, Inc. operates as an oncology-focused biopharmaceutical company in the United States. The company develops antibody therapeutics based on its Probody technology platform for the treatment of cancer. The company's product candidates include CX-2009, an antibody drug conjugates (ADC) against CD166, which is in Phase II clinical...